OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals

• T. Struyve,
• M. Pardons,
• L. Termote,
• J. De Clercq,
• L. Lambrechts,
• J. Vega,
• D. Boden,
• M. Lichterfeld,
• S. Rutsaert,
• L. Vandekerckhove

Affiliations

T. Struyve

HIV Cure Research Center, Ghent University, Ghent, Belgium

M. Pardons

HIV Cure Research Center, Ghent University, Ghent, Belgium

L. Termote

HIV Cure Research Center, Ghent University, Ghent, Belgium

J. De Clercq

HIV Cure Research Center, Ghent University, Ghent, Belgium

L. Lambrechts

HIV Cure Research Center, Ghent University, Ghent, Belgium

J. Vega

Arcturus Therapeutics, Science Center Drive, San Diego, California, USA

D. Boden

Janssen Biopharma, Johnson And Johnson, South San Francisco, USA

M. Lichterfeld

Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA

S. Rutsaert

HIV Cure Research Center, Ghent University, Ghent, Belgium

L. Vandekerckhove

HIV Cure Research Center, Ghent University, Ghent, Belgium